Table: OncoTherapy Science -6-MTH group results

OncoTherapy Science

30/10/2015 08:00

Oct 30 (Reuters)-  
             OncoTherapy Science Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales            208 mln             351 mln                     
                 (-40.8 pct)         (+5.4 pct)                    
  Operating       loss 1.47           loss 1.08                    
  Recurring       loss 1.47           loss 1.06                    
  Net             loss 1.33         loss 747 mln                   
  EPS           loss 9.08 yen       loss 5.10 yen                  
  Ann Div                                NIL              NIL      
  -Q2 div 
  -Q4 div                                NIL              NIL      
   
  NOTE - OncoTherapy Science Inc engages in R&D of cancer drugs.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T  
  ((Tokyo Headline News Desk +813 6441 1812))